Work

Mutation in BRAF V600E: A Poor Prognostic Marker in Stage III Colon Cancers With Deficient MMR?—Reply

Year: 2017

Type: article

Source: JAMA Oncology

DOI: 10.1001/jamaoncol.2017.1474

Authors: Frank A. Sinicrope, Qian Shi, Steven R. Alberts

Institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota), Alliance for Clinical Trials in Oncology

Language: English

Topic: Genetic factors in colorectal cancer

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2625947753

FWCI:

Cites: 5

Cited by:

Related to: 10